David Cooper
Pfizer (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, Viral gastroenteritis research and epidemiology, COVID-19 Clinical Research Studies, Animal Virus Infections Studies
Most-Cited Works
- → Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine(2020)15,281 cited
- → Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates(2020)2,701 cited
- → COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses(2020)2,020 cited
- → Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults(2020)1,577 cited
- → Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents(2021)921 cited
- → Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants(2023)874 cited
- → BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans(2021)818 cited
- → Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera(2021)672 cited
- → Neutralizing Activity of BNT162b2-Elicited Serum(2021)631 cited
- → Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age(2021)616 cited